EVO ICL

See the World As it’s Meant to Be Seen

EVO ICL, also known as the Implantable Collamer® Lens, is a cutting-edge technology and minimally invasive procedure used to help correct the most common visual problem, near-sightedness (known as myopia).

Schedule a Consultation

What Is EVO ICL, and Is It Right for you?

Unlike LASIK or laser vision correction, the EVO ICL is a reversible procedure. The EVO ICL is an ultra-thin lens implant that is an attractive alternative to other procedures used to correct near-sightedness. The EVO ICL is an additive vision correction procedure—it adds a corrective lens to fix nearsightedness. Amazingly, the EVO ICL can correct or significantly reduce nearsightedness of up to -20D (nearly twice that of LASIK!). Candidates may have between -3D to -20D of nearsightedness and up to 4D of astigmatism. In March 2022, the FDA approved the newest iteration of the implant, the EVO ICL, which has been in use abroad since 2007. We are pleased to be able to provide this new technology at Philadelphia Eye Associates.

Biocompatible Material

The EVO ICL’s proprietary lenses are made of biocompatible Collamer. That means the lens material works in harmony with the natural chemistry of your eye and body. Because the procedure avoids removing or reshaping the eye (specifically, the cornea) it means that vision correction can be achieved while minimizing the induction of dry eye syndrome associated with LASIK.

The EVO ICL Procedure & Recovery

The EVO ICL procedure has been refined down to a quick and comfortable process. Most procedures are completed within 20-30 minutes or less. With a minimally invasive procedure, many achieve improved vision nearly immediately.

EVO ICL Results

99% of patients report satisfaction with the EVO ICL and many achieve excellent night vision. Even patients who do not qualify for LASIK due to thin or steep corneas may be great candidates for the EVO ICL.